MYC and cancer: Besides this role we describe for HMGA1 in predicting chemotherapy response, the role described for HMGA1 as a glycolysis regulator in gastric cancer suggests that the HMGA1-c-Myc-glycolysis axis may also be used as a new target in cancer therapy in combination with commonly used chemotherapeutic agents [17].